NAD+ vs NMN
Last updated
The key difference
NMN is a direct precursor that cells convert into NAD+. In peptide contexts NAD+ is typically injected or infused, while NMN is usually taken orally. Both are studied for age-related decline in NAD+ levels.
Side by side
- Supports cellular ATP and energy metabolism
- Provides substrate for sirtuin-mediated longevity pathways
- Aids PARP-driven DNA repair processes
- Studied for improved mitochondrial function
- Directly raises cellular NAD+ levels
- Supports sirtuin-driven longevity pathways
- Studied for improved insulin sensitivity and metabolic health
- Investigated for enhanced mitochondrial energy production
- Flushing, nausea, or cramping, especially with rapid IV infusion
- Injection-site discomfort with subcutaneous use
- Transient lightheadedness or chest tightness during infusion
- Headache
- Generally well tolerated in short human trials
- Possible mild nausea or stomach upset
- Transient headache or flushing
- Limited long-term human safety data
How NAD+ works
Nicotinamide adenine dinucleotide (NAD+) is a redox coenzyme that shuttles electrons in glycolysis, the citric acid cycle, and oxidative phosphorylation to generate ATP. Beyond energy metabolism it serves as a required substrate for sirtuins, which regulate gene expression and mitochondrial biogenesis, and for PARP enzymes involved in DNA repair, as well as CD38 in immune signaling. Cellular NAD+ levels decline with age, impairing these pathways, so direct administration or precursor loading aims to restore the NAD+ pool. Replenished NAD+ is investigated for improving mitochondrial efficiency, stress resistance, and markers of biological aging.
Full NAD+ profile →How NMN works
Nicotinamide mononucleotide (NMN) is generated from nicotinamide and PRPP via NAMPT and is converted to NAD+ by the NMNAT family of enzymes, placing it one step from NAD+ in the salvage pathway. By supplying this precursor, NMN raises intracellular NAD+ pools that fuel sirtuin activity, PARP-mediated DNA repair, and mitochondrial energy metabolism. Cellular uptake is supported by the transporter Slc12a8 in some tissues, allowing NMN to bypass slower de novo synthesis. The resulting increase in NAD+ availability is the basis for NMN's investigated effects on metabolic flexibility, vascular function, and biological aging.
Full NMN profile →Dosing shown is what research and community sources report, not a recommendation. For educational and research purposes only; not medical advice. How we source this